Attention Deficit/Hyperactivity Disorder
Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.
These results may mitigate concerns by physicians regarding the pharmacological treatment of individuals with ADHD.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
After a median of 25 years of follow-up, 2.4% of those born to a parent with a type 1 diabetes diagnosis were diagnosed with ADHD, compared with only 1.5% of the matched controls.
There is an increase in ADHD medication prescriptions in reproductive-aged women.
Clinical differences may exist between the pharmacological and non-pharmacological treatments commonly used for the management of ADHD.
Children and teens who used stimulants for attention-deficit/hyperactivity disorder had lower bone mineral content and bone density than nonusers.
Patients with comorbid bipolar disorder and ADHD may benefit from methylphenidate treatment, if it can be done without incurring the risk of mania.
Investigators used decomposition methods to examine the relative importance of genetic and environmental components to the burden of ADHD.
These findings are important, as CDC rank alcohol-attributable mortality as the third leading cause of preventable death in the United States.
Investigators developed a test [The Test of Playfulness (ToP)] in order to examine children's play skills in peer-to-peer play interactions.
Neuropsychological findings indicate that similar executive functions are affected in ADHD and OCD, but new neuroimaging data indicate differences exist in brain structure and function.
While there is no cure for ADHD, currently available treatments such as medication, psychotherapy, education, or training can help reduce symptoms and improve functioning.
Children with ADHD may adapt more poorly to changing positive reinforcements compared with typically developing children.
For some people, symptoms of ADHD do not emerge until after childhood.
Study is first to investigate the influence of relative age on ADHD diagnosis and treatment in an Asian country.
Clinicians should realize the potential harm ADHD medications may pose to maturing bones, and consider nutritional counseling.
From 1981 to 1997, time spent teaching 3- to 5-year-olds letters and numbers increased 30%.
Both scales yield moderate sensitivity for diagnosing ADHD in children and adolescents.
Telepsychiatry could help with the major shortage of psychiatrists in the US.
Findings are contrary to suggestions that the most severe misuse of Adderall is among older children.
Although not usually considered as part of primary treatment, nutrition addresses the crucial link between food and brain functioning.
Preemies may possess elevated levels of characteristics that put them at risk for peer victimization, including more anxiety and depression.
The risk increased with longer follow-up, was greater in males and was particularly associated with olanzapine.
Lumos Labs, the creators of Lumosity, will pay $2 million to settle Federal Trade Commission charges.
Children with ADHD had weaker connections between three brain networks than children without the condition.
A new analysis suggests that 5.8 million U.S. children between the ages of 5 and 17 currently have ADHD.
QuilliChew ER is the first long-acting, chewable methlyphenidate treatment for ADHD.
Review highlights need for long-term, large, better-quality randomized trials.
The researchers found that both methylphenidate medications like Ritalin and amphetamines like Adderall cause sleep problems.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- Prevalence of ADHD Relatively Stable Over Time Despite Increase in Diagnoses
- Genetic Variations Associated With Empathy Affect Psychiatric Conditions
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders
- Mortality Rates for Substance Use Disorders, Intentional Injuries Vary Widely By Country
- Facial Emotion Recognition Differentiates Behavioral Variant Frontotemporal Dementia From MDD
- The Challenge of Helping Uninsured Patients While Protecting Practice Finances
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed